Benjamin F. Wyse

Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease

B. F. Wyse, J. Phillips, C. F. Underwood, 2015, Clinical and experimental pharmacology & physiology.

Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?

A. Goodchild, C. Hildreth, B. F. Wyse, 2017, Acta physiologica.

Renal denervation does not affect hypertension or the renin-angiotensin system in a rodent model of juvenile-onset polycystic kidney disease: clinical implications

Sheran Li, C. Hildreth, A. Rahman, 2021, Scientific Reports.

Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease

B. F. Wyse, J. Phillips, P. Witting, 2012, Clinical and experimental pharmacology & physiology.